MERIT MEDICAL SYSTEMS INC (MMSI) Stock News
NASDAQ:MMSI - Nasdaq - US5898891040 - Common Stock - Currency: USD
MMSI Latest News, Press Relases and Analysis
ALGN vs. MMSI: Which Stock Should Value Investors Buy Now?
ALGN vs. MMSI: Which Stock Is the Better Value Option?
Mentions: ALGN
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio
Merit Medical aims to provide an additional effective solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology.
Why QXO Stock Is Down Today
QXO announced a secondary offering to replenish its cash reserves. QXO (NYSE: QXO) is restocking its war chest, but that comes with a near-term hit to existing holders. Shares of QXO traded down 10% as of 11 a.m. ET after the building products distribution company launched a new stock and convertible offering.
Lexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside Potential
We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) was one of the stocks that was covered in that article. Wall Street analysts believe LXRX has a 285% upside potential over the next 12 months. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) is a biopharmaceutical company with a pioneering approach […]
LH vs. MMSI: Which Stock Is the Better Value Option?
LH vs. MMSI: Which Stock Is the Better Value Option?
Mentions: LH
Apollo to Fund $2B PowerGrid Acquisition with $1B Private Debt
Apollo Global Management Inc. (NYSE:APO) is financing its ~$2 billion acquisition of PowerGrid Services from Sterling Group through a ~$1 billion private debt package, as reported by Bloomberg on Tuesday. This financing is being provided by the direct lending businesses of Brookfield Asset Management, Blackstone Inc., and JPMorgan Chase & Co. The debt package includes […]
ASP Isotopes Enters into Agreement For Potential Acquisition of Renergen
On May 20, ASP Isotopes Inc. (NASDAQ:ASPI) announced entering an agreement for the potential acquisition of Renergen Limited to create an international critical materials company. As per the release, this acquisition aims to combine two highly complementary businesses to form a critical materials production company specializing in electronic gases such as helium, fluorinated products, and […]
Merit Medical Acquires Biolife Delaware, L.L.C.
Acquired business offers the StatSeal® and WoundSeal® products, which provide hemostasis solutions that complement the wide range of procedures Merit’s...
Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
The WRAPSODY CIE is designed to help physicians prolong functional vascular access in hemodialysis patients.Approval was supported by superior 12-month...
Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
In the AVG cohort of the US pivotal trial, the Merit WRAPSODY Cell-Impermeable Endoprosthesis (CIE) achieved 60.2% target lesion primary patency (TLPP) at...
Strong Quarterly Results Lifted Merit Medical Systems (MMSI) in Q1
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical […]
Was Jim Cramer Right About Enterprise Products Partners L.P. (EPD)?
We recently published a list of Did Jim Cramer Nail All These 9 Stock Predictions?w. In this article, we are going to take a look at where Enterprise Products Partners L.P. (NYSE:EPD) stands against other stocks that Jim Cramer discussed. During a recent Mad Money episode, Jim Cramer discussed how President Donald Trump’s influence shapes […]
RBC Bearings (RBC) Rose as Results and Guidance Exceeded Expectations
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical […]
Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings?
The continued solid uptake of BD's products is expected to have driven fiscal second-quarter revenues despite transitory market dynamics.
Compared to Estimates, Merit Medical (MMSI) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates
Merit Medical (MMSI) delivered earnings and revenue surprises of 14.67% and 0.86%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MCK
Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance
First Quarter Highlights† Reported revenue of $355.4 million, up 9.8%Constant currency revenue* and constant currency revenue, organic* up 10.9% and up...
Labcorp (LH) Earnings Expected to Grow: Should You Buy?
Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: LH
Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings?
West Pharmaceutical Services' first-quarter results are likely to reflect growth amid pharma stabilization, biologics rebound & contract manufacturing gains.
Is TuHURA Biosciences, Inc. (HURA) the Best Rising Penny Stock to Buy According to Analysts?
We recently published a list of the 10 Best Rising Penny Stocks to Buy According to Analysts. In this article, we are going to take a look at where TuHURA Biosciences, Inc. (NASDAQ:HURA) stands against other best rising penny stocks to buy according to analysts. Small-Cap Performance in Q1 2025 The start of 2025 was […]
Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks to Watch as Dental Supplies Recovers Amid Tariff Headwind
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, MMSI, XRAY and CNMD.
Merit Medical Launches the Ventrax™ Delivery System
Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia...
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of...